Mercodia is a world-leading developer, manufacturer and provider of high quality immunoassay kits. With the stringent quality system inherited from Pharmacia Diagnostics, the initial business concept of Mercodia was to develop robust and accurate ELISA assays for use in human diagnostics. The increased demand from pharmaceutical and academic research for reliable assays that ensure reproducible results created an interest from researchers around the world for Mercodia’s products and services.
Mercodia specializes in ELISA assays for clinical as well as research applications, notably within diabetes, obesity and cardiovascular disease. Assays applicable in both human and animal models are offered.
Mercodia supplies products and services to all major international markets from its facilities in Uppsala, Sweden. More than ninety percent of our production is exported to approximately 100 countries worldwide.
The US subsidiary, Mercodia Inc, is based in Winston Salem, North Carolina and is involved in direct sales, distribution and support to North American customers. Mercodia provides a professional support system by collaborating with worldwide customers and institutions to develop new applications for existing products and new diagnostics for emerging markets.
Mercodia is the preferred choice of leading researchers around the world.
- Immunoassays for validation of diabetes biomarkers
- Mercodia launches new product